William FarringtonHe owes nearly $1.7 million to financial services firm Marks Paneth, a Manhattan Supreme Court filing says.Hewhen his Turing Pharmaceuticals acquired the rights to the life-saving cancer and AIDS drug Daraprim, and jacked the price from $13.50 per pill to $750.
Shkreli — banned from the pharmaceutical industry for life — was sentenced to seven years in prison and was released last year.“I owe Marks Paneth $1,695,063.00 in professional service fees for work performed on my behalf,” Shkreli, who was released from prison last year and now lives in Elmhurst, Queens, wrote in recently filed legal papers affirming the debt.
A lawyer for Marks Paneth did not respond to a message seeking comment and it’s unclear what work the company did for Shkreli.